It appears that the RANK/RANKL signaling pathway is involved in all stages of the development of breast cancer, from the expansion of the partition and enhancement of the proliferation of epithelial cells to increasing the resistance of tumor cells in anticancer therapy as well as the promotion of damaging agents and metastatic potential [51]. This evidence concerns the gene TNFRSF11A and breast cancer.